With the recent outbreak of the novel coronavirus (COVID-19) in the US, InCrowd wanted to understand how patients with chronic conditions and those who are immunocompromised have been impacted by the virus, and how they anticipate ways in which their lives and disease management will be affected moving forward.
We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.
- Method: 9-minute MicroSurvey via InCrowd & Rare Patient Voice
- Crowds: Patients with Mild to Severe Illness
- Sample Size: n=152 (77 Mild to Moderate Patients, 75 Moderate to Severe Patients)
- Fielding Period: March 25-26, 2020
InCrowd’s other COVID-19 Tracking Reports: